Dr. Vicky A. Lazarou

Cosmetic Dermatology: Dermal Fillers and Injectables, Botox, Laser skin resurfacing, Collagen induction therapy, Wrinkles, Sun spot removal, Acne, Diamond Glow, PRP Therapy, Microneedling (SkinPen, Microneedling RF).

Clinical Dermatology: Atopic Dermatitis, Skin Lymphoma, Alopecia Areata, Psoriasis, Hidradenitis Suppurativa, Mole Mapping, Dermoscopy-Punch Biopsy, Surgical Removals BCC-SCC.

⮚ HORIZON: A Phase 2, multicenter, randomized, double-blind, placebo-controlled, parallel-group trial
Protocol Number: HZNP-DAX-202.
Investigating the efficacy and safety of subcutaneous infusion of daxdilimab in reducing disease activity in adult participants with moderate to severe primary discoid lupus erythematosus.

⮚ RESMAIN Study: A multicenter, double-blind, randomized, placebo-controlled, Phase II trial
Evaluating Resminostat for maintenance treatment of patients with advanced stage (Stage IIB-IVB) mycosis fungoides (MF) or Sézary Syndrome (SS) that have achieved disease control with systemic therapy.

⮚ MOGAT Study: Open-Label, Phase II, Multi-Center study
Investigating Anti-CCR4 Monoclonal Antibody (mogamulizumab) Plus Total Skin Electron Beam Therapy (TSEB) in patients with stage IB-IIB Cutaneous T-cell lymphoma.

⮚ HELSINN Study: A Greek, prospective non-interventional study
Investigating the effectiveness and the mechanism of action of Chlormethine (CL) gel in the treatment of MF-CTCL adult patients.

⮚ MSD Study: A Phase 3,randomized, double-blind, placebo-controlled Study
Protocol Number: 630-08.
Evaluating Pembrolizumab Versus Placebo as Adjuvant Therapy Following Surgery and Radiation in Participants with High-risk Locally Advanced Cutaneous Squamous Cell Carcinoma (LA cSCC).

◇ Diagnosed and treated over 1000 patients with diverse dermatological conditions.
◇ Assisted in more than 300 dermatological surgeries and procedures, achieving a success rate of 98%.
◇ Collaborated with multidisciplinary teams to develop and implement treatment plans and clinical care for complex cases, resulting in improved patient outcomes.
◇ Contributed to 5 published research papers in renowned medical journals, focusing on advancements in dermatology.

◇ Diagnosed and treated over 800 patients with pathological conditions and COVID infection.
◇ Adapted to the dynamic and challenging healthcare environment during the COVID pandemic.
◇ Demonstrated strong interpersonal skills in providing care to a diverse range of patients.
◇ Collaborated with healthcare teams to develop and implement treatment plans and clinical care for complex cases, resulting in improved patient outcomes.

◇ Accurately entered and maintained data in the database, averaging 500 entries per week with a 99.8% accuracy rate.
◇ Ensured data integrity and confidentiality by strictly following established protocols.
◇ Collaborated with team members to streamline data entry processes, reducing processing time by 25% while maintaining accuracy.
◇ Conducted regular audits to identify and rectify errors, contributing to improved data quality and reliability.

◇ Successfully organized and executed over 50 party events, ensuring a memorable experience for clients and guests.
◇ Coordinated logistics for each event, including venue selection, catering, entertainment, and decorations.
◇ Managed event budgets totaling over €500,000, negotiating contracts with vendors to optimize costs and quality.

◇ Successfully promoted and marketed dermatological products, resulting in a 20% increase in product awareness and a 15% increase in sales.
◇ Conducted over 50 product presentations and training sessions for medical professionals, ensuring comprehensive understanding and adoption of promoted products.